Divorce Adjustment Program for Women
Launched by DOKUZ EYLUL UNIVERSITY · Oct 9, 2023
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special program designed to help women adjust after going through a divorce. The program, called the Divorce Adjustment Program (DAP), is structured to be sensitive to different cultures and will be delivered in an online group setting. Women who participate will be compared to a group that will not receive the program right away, to see how effective and helpful the DAP is for those dealing with divorce-related challenges.
To be eligible for this study, women must be legally divorced and experiencing difficulties adjusting to their new situation. They should not be remarried or currently in a romantic relationship, and they should not be receiving therapy at the same time. Participants can expect to attend group sessions online, where they will learn strategies to cope with their feelings and experiences related to divorce. Researchers will monitor how many women attend the sessions and gather feedback to understand how helpful the program is. This trial is not recruiting participants yet, but it aims to provide valuable support for women navigating the aftermath of divorce.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being legally divorced
- • Adjustment difficulties to divorce as indicated by having a FDAS-SF score of 98 or below for those with children and 94 or below for those without children (these scores are the average scores determined in the FDAS-SF Turkish adaptation study)
- • Not being remarried or involved in a current romantic relationship
- • Not receiving concurrent psychotherapy
- Exclusion Criteria (as determined by the Diagnostic and Statistical Manual-5 \[DSM-5\] Level 1 Cross-Cutting Symptom Measure and a confirmatory telephone screening with the eligible participants):
- • Substance use problems
- • Suicidal thoughts
- • Psychotic symptoms
About Dokuz Eylul University
Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported